The impact of anticancer therapy on antitumor immunity in patients with thoracic cancers

The impact of anticancer therapy on antitumor immunity in patients with thoracic cancers - Anticancer therapy and antitumor immunity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027520

Enrollment

100

Registered

2017-05-29

Start date

2016-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, thymoma, thymic cancer, malignant mesothelioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with thoracic cancers who are treated with 1st line chemotherapy, radical radiotherapy, or immunotherapy.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
The impact of anticancer therapy on antitumor immunity in patients with thoracic cancers.	—

Countries

Japan

Contacts

Public ContactSatoshi Watanabe

Niigata University Graduate School of Medical and Dental Sciences Department of Respiratory Medicine and Infectious Diseases

satoshi7@med.niigata-u.ac.jp025-368-9325

Outcome results